US44984F4019 - Common Stock
What's going on in today's session
Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning!
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Which stocks are moving before the opening bell on Thursday?
Get insights into the top gainers and losers of Wednesday's after-hours session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.
Trio Petroleum stock is falling on Wednesday as TPET investors learn of a securities purchase agreement and Senior Secured Note.
Trilogy Metals stock is falling on Wednesday as TMQ investors react to reports that the government plans to block its Ambler Access Project.
Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares.
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Invo Bioscience stock is rising higher on Wednesday as INVO investors celebrate the company's latest earnings results for Q4 2023.
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!
INVO Bioscience just reported results for the fourth quarter of 2023.
SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intravaginal culture ("IVC") procedure enabled by its INVOcell® medical device, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023 and provided a business update.
NAYA Biosciences plans to acquire Florida Biotechnologies Inc, a gene therapy company focusing on mitochondrial diseases, in a $20M stock deal.
INVO Bioscience (INVO) and NAYA Biosciences said they expect their planned merger to close in Q1 and announced several additions to their future combined board. Read more here.
NAYA Biosciences, which is merging with INVO Bioscience (INVO), is teaming up with ONK Therapeutics to explore combination therapies for cancer. Read more here.
INVO Bioscience has regained compliance with Nasdaq's minimum stockholders' equity requirement.
It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!